Expert Review of Neurotherapeutics · 2021 · 41 citations · 104 references
MedicineNeurologyNeuroscienceDysphagiaMovement DisordersNeuropsychiatryMovement Disorder PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersComorbid Sleep DisturbancesDopamine-related Movement DisordersDopaminergic Therapy ManagementNeuropsychiatric ManifestationsParkinson's Disease Palliative CareParkinson's Disease PharmacotherapyParkinson’s Disease TreatmentSleepiness In Parkinson Disease
: The NMS progression pattern is complex and remains under-researched. While dopamine-dependent NMS may improve with dopamine replacement therapy, non-dopamine dependent NMS worsen progressively and culminate at the late stages of PD. Furthermore, some PD specific features could interact negatively with other comorbidities, multiple medication use and frailty - the evaluation of these aspects is important in the creation of personalized management plans in the late stage of PD.
104
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
M. A. Hely, Wayne G.J. Reid, Michael Adena et al. · Movement Disorders · 2008 · 2.2K citations · Full text
Medicine, Neurology, Neuroscience +12
Rivastigmine for Dementia Associated with Parkinson's Disease
Murat Emre, Dag Aarsland, Alberto Albanese et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text
К. Ray Chaudhuri, Pablo Martínez‐Martín, Anthony H.V. Schapira et al. · Movement Disorders · 2006 · 1.1K citations